title: Therapeutic targeting of tumor-associated macrophages and microglia in glioblastoma.
authors.affiliation: Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
authors.forename: Robert L
authors.initials: RL
authors.lastname: Bowman
authors.forename: Johanna A
authors.initials: JA
authors.lastname: Joyce
mesh_terms: D000818:Animals; D052160:Benzothiazoles / Q000494:pharmacology; D001932:Brain Neoplasms / Q000188:drug therapy / Q000276:immunology* / Q000532:radiotherapy; D059248:Chemoradiotherapy; D005909:Glioblastoma / Q000188:drug therapy / Q000276:immunology* / Q000532:radiotherapy; D006801:Humans; D008264:Macrophages / Q000187:drug effects / Q000276:immunology* / Q000528:radiation effects; D017628:Microglia / Q000187:drug effects / Q000276:immunology* / Q000528:radiation effects; D010848:Picolinic Acids / Q000494:pharmacology; D016186:Receptor, Macrophage Colony-Stimulating Factor / Q000037:antagonists & inhibitors / Q000276:immunology / Q000378:metabolism; D016896:Treatment Outcome; D059016:Tumor Microenvironment / Q000187:drug effects / Q000276:immunology / Q000528:radiation effects
chemical_list: C568289:4-(2-(2-hydroxycyclohexylamino)benzothiazol-6-yloxy)pyridine-2-carboxylic acid methylamide; D052160:Benzothiazoles; D010848:Picolinic Acids; D016186:Receptor, Macrophage Colony-Stimulating Factor